Latest Governance News

Peregrine Gold Limited has announced a major discovery of a high-grade Channel Iron Deposit spanning over 7.7km near key BHP iron ore operations in Western Australia. Initial assays reveal iron grades averaging 57%, highlighting significant potential for the Newman Gold Project.

Broken Hill Mines Limited will have its trading suspension lifted on 21 July 2025, marking its return to the ASX following successful compliance with listing rules.

Strata Minerals reports promising maiden drilling results at its Penny South Gold Project and high-grade sampling at Biranup, backed by a government co-funded drilling grant and fresh capital raise.

Yancoal Australia is set to increase its ownership in the Moolarben Joint Venture from 95% to 98.75% through a $110.5 million acquisition, combining upfront and deferred payments linked to coal prices.

Rincon Resources Limited has announced a non-renounceable entitlement offer to issue options aimed at raising approximately $97,520, fully underwritten by Golden Triangle Capital Pty Ltd. The offer may lead to a 25% dilution if all options are exercised.

Resolution Minerals has addressed ASX concerns over recent share price and volume spikes, attributing the activity to ongoing developments in its US Horse Heaven project acquisition.

Yowie Group has arranged a $1 million short-term funding facility from parent Keybridge Capital to manage cash flow while investigating former directors' use of funds and intra-group loans.

Yugo Metals Limited has launched a $100,000 capital raising through a new options offer, aiming to bolster working capital while navigating significant geopolitical and operational challenges in Bosnia and Herzegovina.

Magnetic Resources NL has reported a significant 22% increase in gold resources at its Lady Julie Gold Project, now containing over 2.14 million ounces, while securing a key Native Title Agreement that clears the path for mining leases and development.

Sipa Resources has successfully raised A$1.61 million through a strongly supported placement, positioning the company to advance multiple gold exploration projects across South Australia and Western Australia.

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.

American Rare Earths is progressing its Halleck Creek Rare Earths Project with multiple mineral processing optimisation tests, ordering critical equipment for a demonstration plant, and initiating test mining to secure bulk samples.